DNA Repair Capacity in Peripheral Lymphocytes Predicts Survival of Patients With Non–Small-Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy

PURPOSE: Platinum-based regimens are the standard chemotherapy for patients with advanced non–small-cell lung cancer (NSCLC). DNA repair capacity (DRC) in tumor cells plays an important role in resistance to platinum-based drugs. We have previously reported that efficient DRC, as assessed by an in v...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wang, Li-E, Yin, Ming, Dong, Qiong, Stewart, David J., Merriman, Kelly W., Amos, Christopher I., Spitz, Margaret R., Wei, Qingyi
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2011
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3675702/
https://ncbi.nlm.nih.gov/pubmed/21947825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.34.3616
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars